Many PCPs recommend colorectal cancer screening in elderly

This article originally appeared here.
Share this content:
Many PCPs Recommend Colorectal Cancer Screening in Elderly
Many PCPs Recommend Colorectal Cancer Screening in Elderly

(HealthDay News) -- A substantial portion of primary care physicians (PCPs) recommend screening elderly patients with advanced cancer for colorectal cancer (CRC), according to a study published online June 1 in the Journal of General Internal Medicine.

David A. Haggstrom, M.D., from the VA Medical Center in Indianapolis, and colleagues analyzed survey results from 1,266 PCPs (internal medicine, family practice, and obstetrics-gynecology physicians). Physician CRC screening recommendations were assessed based upon clinical vignettes.

The researchers found that 25 percent of PCPs recommended CRC screening for an 80-year-old patient with unresectable non-small-cell lung cancer (NSCLC). Obstetrician-gynecologists were more likely to recommend CRC screening for these patients, while physicians with a full electronic medical record were less likely to do so. Seventy-one percent of PCPs recommended CRC screening for an 80-year-old patient with ischemic cardiomyopathy (New York Heart Association, Class II). Fecal occult blood testing (FOBT) was recommended as the preferred screening modality rather than colonoscopy for 19 percent of healthy 80-year-olds, 5 percent of healthy 50-year-olds, and 2 percent of healthy 65-year-olds.

"PCPs consider comorbidity when screening older patients for CRC and may change the screening modality from colonoscopy to FOBT. However, a sizable proportion of PCPs would recommend screening for patients with advanced cancer who would not benefit," the authors write.

Full Text (subscription or payment may be required)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs